Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 785 | 0 | 0 | 0 | 0 |
| Gross Profit | 785 | N/A | N/A | N/A | N/A |
| Operating Expenses | 1,747 | 740 | 1,422 | 750 | 882 |
| Operating Income | -962 | -740 | -1,422 | -750 | -882 |
| Interest Expense | 6 | 0 | 18 | 17 | 17 |
| Other Income | 4,740 | -6,880 | -11,448 | -3,856 | 7,817 |
| Pre-tax Income | 3,772 | -7,620 | -12,888 | -4,623 | 6,918 |
| Net Income Continuous | 3,772 | -7,620 | -12,888 | -4,623 | 6,918 |
| Net Income | $3,772 | $-7,620 | $-12,888 | $-4,623 | $6,918 |
| EPS Basic Total Ops | 0.06 | -0.13 | -0.24 | -0.10 | 0.14 |
| EPS Basic Continuous Ops | 0.06 | -0.13 | -0.25 | -0.10 | 0.14 |
| EPS Diluted Total Ops | 0.03 | -0.13 | -0.17 | -0.10 | 0.07 |
| EPS Diluted Continuous Ops | 0.03 | -0.13 | -0.18 | -0.10 | 0.07 |
| EBITDA(a) | $-962 | $-740 | $-1,422 | $-750 | $-882 |